Sfoglia per AUTORE
TISEO M
Collezione AOU Alessandria

  

Items : 8

2026
AOU Alessandria

Pasello G; Scattolin D; Faccioli E; Zucali PA; Marulli G; Grosso F; Ceresoli GL; Tiseo M; Bearz A; Cecere FL; Calabrò L; Callegarin F; Del Bianco P; De Salvo GL; Pezzuto F; Calabrese F; Guarneri V; Dell'Amore A; Rea F;

Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2026 Feb 5;234:116191. doi: 10.1016/j.ejca.2025.116191. Epub 2025 Dec 24.
2026
AOU Alessandria

Stanzione B; Buffoni L; Parra HS; Toschi L; Buosi R; Chiari R; D'Aveni A; Pedrazzoli P; Pasello G; Vavalà T; Gori S; Scotti V; Genova C; Meoni G; Sergi C; Ricciardi S; Signorelli D; Pavan A; Bettini A; Alì G; Pelizzari G; Minuti G; Pizzutilo P; Calvetti L; Roca E; Reale ML; Pignataro D; Pilotto S; Antonuzzo L; et alii...

Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study. in Cancer treatment and research communications / Cancer Treat Res Commun. 2026;47:101143. doi: 10.1016/j.ctarc.2026.101143. Epub 2026 Feb 16.
2026
AOU Alessandria

Pasello G; Cecere FL; Bertolini A; Aieta M; Gori S; Livi L; Borra G; Piovano PL; Ferrara R; Vattemi E; Sergi C; Gregorc V; Berardi R; Zanelli F; Verderame F; Giusti R; Macerelli M; Ciuffreda L; Carta AM; Brighenti M; Borghetti P; Rijavec E; Cortinovis D; Bria E; Tagliaferri P; Pilotto S; Lugini A; Gridelli C; Ceresoli GL; et alii...

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. in Journal of personalized medicine / J Pers Med. 2024 Apr 8;14(4):394. doi: 10.3390/jpm14040394.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Galetta D; Ceresoli GL; Davolio MC; Dianzani I; Abate-Daga L; Sculco M; Malapelle U; Pisapia P; Grosso F; Spagnolo P; Tiseo M; Barbisan F; Righi L; Rossi G; Pasello G; Novello S; Bironzo P;

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Oct;22(10):1438-1447. doi: 10.1016/S1470-2045(21)00404-6. Epub 2021 Sep 6.
2021
AOU Alessandria

Pinto C; Zucali PA; Pagano M; Grosso F; Pasello G; Garassino MC; Tiseo M; Soto Parra H; Grossi F; Cappuzzo F; de Marinis F; Pedrazzoli P; Bonomi M; Gianoncelli L; Perrino M; Santoro A; Zanelli F; Bonelli C; Maconi A; Frega S; Gervasi E; Boni L; Ceresoli GL;

Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study. in Clinical lung cancer / Clin Lung Cancer. 2021 Jul;22(4):361-370.e3. doi: 10.1016/j.cllc.2020.06.028. Epub 2020 Jul 3.
2021
AOU Alessandria

Maconi A; Canova S; Rulli E; Torri V; Galli F; Hollander L; Sperandi F; Tiseo M; Pasello G; Zucali PA; Carlucci L; Grosso F; Cortinovis D; Bidoli P; Ceresoli GL; D'Incalci M;

Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study. in Cancers / Cancers (Basel). 2020 Oct 13;12(10):2948. doi: 10.3390/cancers12102948.
2020
AOU Alessandria

Pagano M; Ceresoli LG; Zucali PA; Pasello G; Garassino M; Grosso F; Tiseo M; Soto Parra H; Zanelli F; Cappuzzo F; Grossi F; De Marinis F; Pedrazzoli P; Gnoni R; Bonelli C; Torricelli F; Ciarrocchi A; Normanno N; Pinto C;

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. in The Lancet. Oncology / Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12.
2020
AOU Alessandria

Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; et alii...